BRIEF published on 05/23/2024 at 06:50, 1 year 6 months ago Galenica stays the course with sales growth Pharmaceutical Growth Turnover Galenica Generics
PRESS RELEASE published on 05/23/2024 at 06:45, 1 year 6 months ago Galenica on track with sales growth Galenica Group reports 4.8% sales growth in the first four months of 2024, driven by positive pharmaceutical market development. Outlook for 2024 confirmed with sales growth between 3% and 5% Sales Growth Outlook 2024 Galenica Group Pharmaceutical Market
BRIEF published on 04/16/2024 at 18:10, 1 year 7 months ago Galenica Successfully Issues CHF 100 Million Bond Corporate Finance SIX Swiss Exchange Bond Issue Financial Stability Galenica AG
PRESS RELEASE published on 04/16/2024 at 18:05, 1 year 7 months ago Galenica successfully places a bond of over CHF 100 million Galenica successfully places a CHF 100 million fixed rate bond with a 7-year term and 1.65% annual coupon. The proceeds will be used for general corporate purposes, securing long-term financing Bond Long-term Financing Galenica AG CHF 100 Million Fixed Rate
BRIEF published on 04/10/2024 at 17:34, 1 year 7 months ago Shareholders of Galenica AG unanimously approve at the 7th Ordinary General Meeting Board Of Directors Dividend Annual Accounts General Assembly Galenica SA
PRESS RELEASE published on 04/10/2024 at 17:29, 1 year 7 months ago 7th Annual General Meeting: Shareholders approve all proposals Galenica Ltd.'s 7th Annual General Meeting sees approval of all proposals, including dividend of CHF 2.20 per share and re-election of Board of Directors members Board Of Directors Annual General Meeting Dividend Approval Galenica Ltd.
BRIEF published on 03/12/2024 at 06:50, 1 year 8 months ago Galenica announces sustained growth in 2023 and optimistic forecasts for 2024 Financial Results Sustainable Development Online Pharmacy Galenica Growth 2024
PRESS RELEASE published on 03/12/2024 at 06:45, 1 year 8 months ago Galenica continues to grow in the 2023 financial year Galenica Group achieves 4.4% sales growth in 2023, proposing stable dividend. Expects 3-5% sales growth in 2024, increased adjusted EBIT by 8-11% 2024 Outlook Sales Growth Dividend Proposal Galenica Group Adjusted EBIT Increase
Published on 12/05/2025 at 02:35, 2 hours 46 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 4 hours 21 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 6 hours 16 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 6 hours 21 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 1 hour 51 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 5 hours 30 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 8 hours 56 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 9 hours 6 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 10 hours 10 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 11 hours 21 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 11 hours 36 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 11 hours 37 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 22 hours 20 minutes ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 11 hours ago Declaration of voting rights at the end of November 2025
